menu-hamburger-svgrepo-com

WEBINAR REPLAY

Drug-resistant epilepsy

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Presented by

:
:
DAYS
HRS
MINS

BOOKINGS

Epilepsy webinar
Macro coronavirus(covid-19) cell delta plus variant. B.1.1.529,B.1640.1,deltacron,COVID 19 variant of SARS-CoV-2 in 2022.Mutated coronavirus SARS-CoV-2 flu disease pandemic,3D render illustration

To watch a replay of this webinar and earn a CPD point, go to: https://event.webinarjam.com/go/replay/575/zk84khqquz7rby1zhv.
Email john.woodford@newmedia.co.za to let him know once you have watched, so that he can allocate your CPD point.

The definition of epilepsy is two or more unprovoked seizures​. Epilepsy can be defined by two or more unprovoked seizures​. Abnormal neuronal firing leads to a clinical alteration of neurologic function, be it motor​, sensory​, autonomic​ or psychological​. Hallmarks of a seizure are neuronal hyperexcitability – reduced threshold for action potential at level of single neuron​, and neuronal hypersynchrony – neurons in a given area firing together​.

Epilepsy is one of the most prevalent neurological conditions, with no predilection for race or age. It is more common than Parkinson's disease, muscular dystrophy, cerebral palsy, and multiple sclerosis combined. Fifty million people worldwide have epilepsy with 2.4 million diagnosed with epilepsy each year​. In-high income countries, this equates to 30-50 new cases per 100 000 and it is up to two times higher in low- and middle-income countries​.

Of the 50 000 000 people with epilepsy​, 75% have inadequate treatment. This ​is based on poor knowledge and stigma​, poor prioritisation within the healthcare system​ and high costs​.

Less than 1% of patients are referred to a full epilepsy centre. Of those who are, the referral may be 20 years after seizure onset.​

Pharmacological treatment options​

Antiepileptic drug (AED) therapy, the mainstay of treatment for most patients, has four goals: ​

  • Eliminate seizures or reduce their frequency​
  • Evade the adverse effects associated with long-term treatment​
  • Aid patients in maintaining or restoring their usual psychosocial and vocational activities​
  • Aid patients in maintaining a normal lifestyle​.

AED therapy decisions should balance these factors to provide optimal seizure relief and QoL for patients.

Despite the development of new AEDs (of which there are now ​more than 24) many patients still suffer from continued seizures.

The failure of ​two appropriately chosen and tolerated AEDs ​(whether as monotherapies or in combination) ​to control seizures when used for an ​adequate period. After adequate trials of at least two AEDs, ​overall seizure freedom rates with subsequent treatment trials are dramatically decreased​. Adding drugs in drug-resistant epilepsy (DRE) may not reduce seizures.

Failure of previous AEDs diminishes seizure-free rates for future AEDs. Patients with DRE suffer the physical, psychological and societal consequences of intractable seizures with a heavy drug burden and an increased mortality.

Sudden unexpected death in epilepsy occurrence is unanticipated and highly traumatic to the families of patients. Sudden cardiac death (SCD) risk is high in epilepsy and sodium channel blocking AEDs contribute to SCD susceptibility​. Risk of accidental death is higher in patients with epilepsy. Status epilepticus is a direct cause of premature death​. Suicide is an external cause of elevated mortality in epilepsy​.

Unmet needs in DRE​

Tackling DRE is one of the most important challenges in epilepsy management​.

Patients may experience complete resistance to AED treatment or may be deemed only partially responsive if seizures are reduced in frequency and/or intensity but not eliminated​.

Conclusion

Early identification of patients with DRE allows effective treatment that may reduce mortality and the potential irreversible psycho-social consequences of continuing seizures​.

Treatment options are evolving rapidly.

Sign in to access full articles and earn your CPD points.

Clinical and CPD content is compiled by Key Opinion Leaders and our expert medical editors.

Already registered? Login here

Past webinars

Suggested clinical & CPD content

Related articles

idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! Your account was successfully created.

Please check your email for an activation mail. Click the activation link to activate your account

Stay up to date

Search for anything across CPD, webinars and journals
idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! You have successfully booked your seat.

All webinar details will be emailed to your email address.

Did you know, you can book future webinars with a single click if you register an account with Medical Academic.

Congratulations! Your account was successfully created.

Your webinar seat has been booked and all webinar details will be emailed to your registered email address

Why not register for Medical Academic while booking your seat for this webinar?

Future Medical Academic webinars can be booked with a single click, all with a Medical Academic account… and it’s FREE.

Book webinar & create your account

* (Required)

idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! Your account was successfully created.

Thank you for registering. You can now log in to your account.

Create your account

* (Required)

Login with One Time Pin (OTP)

Enter your registered email address to receive an OTP

A verification code will be sent to your email address. Please ensure that admin@medicalacademic.co.za is on your safe sender list.

We've sent your OTP
Welcome to Medical Academic​

Get the most out of Medical Academic by telling us your occupation. This helps us create more great content for you and the community.